[1] Wozniak KL, Levitz SM. Isolation and purification of antigenic components of Cryptococcus[J]. Methods Mol Biol, 2009,470(2):71-83.
[2] Cherniak R, Morris LC, Anderson BC, et al. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans[J]. Infect Immun, 1991,59(1):59-64.
[3] 李平, 谭宏月, 胡婵, 等. 新生隐球菌GXM的纯化及其对巨噬细胞甘露糖受体表达调节的研究[J].中国真菌学杂志,2012,7(5):265-268.
[4] Urai M, Kaneko Y, Ueno K, et al. Evasion of innate immune responses by the highly virulent Cryptococcus gattii by altering capsule glucuronoxylomannan structure[J]. Front Cell Infect Microbiol, 2015,5:101.
[5] Rodrigues ML, Fonseca FL, Frases S, et al. The still obscure attributes of cryptococcal glucuronoxylomannan[J]. Med Mycol, 2009,47(8):783-788.
[6] Albuquerque PC, Fonseca FL, Dutra FF, et al. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct[J]. Future Microbiol, 2014,9(2):147-161. |